32R-19310-39157
4 vaccinations
6 coded responses
40 check-ins
6 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 495 / MI
- Registered
- 2021-01-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-08
Dose 1 — Pfizer-BioNTech
-
2021-01-21
Registered in v-safe
- 2021-01-21
- 2021-01-22
- 2021-01-29
-
2021-01-30
Dose 2 — Pfizer-BioNTech
- 2021-01-30
-
2021-01-31
Survey response — days 1–6 daily, dose 2MedDRA: Injection site induration, Injection site inflammation — Feeling: Good · Site: Pain · Muscle or body achesFree text: Slight inflammation at site. Firmness in arm at site about 40cm diameter .MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-13
- 2021-02-20
- 2021-02-27
- 2021-03-06
- 2021-03-13
- 2021-05-01
- 2021-07-31
-
2021-09-28
Dose 3 — Pfizer-BioNTech
-
2021-09-30
Survey response — days 1–6 daily, dose 3MedDRA: No adverse event — Feeling: Good · Site: Pain, SwellingFree text: NoneMedDRA releases: 2024-11 · check-in free text available
- 2021-10-01
- 2021-10-02
-
2021-10-03
Survey response — days 1–6 daily, dose 3MedDRA: Injection site discomfort — Feeling: GoodFree text: Slight discomfort at injection siteMedDRA releases: 2024-11 · check-in free text available
- 2021-10-04
- 2021-10-05
-
2021-10-12
Survey response — day 14, dose 3MedDRA: No adverse event — Feeling: GoodFree text: NoneMedDRA releases: 2024-11 · check-in free text available
- 2021-10-19
- 2021-10-26
- 2021-11-02
- 2021-11-11
-
2021-12-28
Survey response — 3 months, dose 3MedDRA: Chills, Fatigue, Rhinorrhoea — Feeling: GoodFree text: Runny nose. Chills fatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-03-29
-
2022-04-07
Dose 4 — Pfizer-BioNTech
- 2022-04-15
- 2022-04-21
- 2022-04-28
- 2022-05-05
- 2022-05-12
- 2022-05-19
-
2022-07-07
Survey response — 3 months, dose 4MedDRA: Respiratory tract congestion, SARS-CoV-2 test positive, Viral infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: Covid positive antigen june 18. Took Paxlovid. With significant improvement. Had rebound and receive script for second round of Paxlovid but did not have to take. I weathered the storm and now I just have slight congestion with no fever. · Healthcare visit (other): Got Script for anti viralMedDRA releases: 2024-11 · check-in free text available
-
2022-07-07
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-07-08
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-10-06
- 2023-04-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-08 | Pfizer-BioNTech | |
| 2 | 2021-01-30 | Pfizer-BioNTech | |
| 3 | 2021-09-28 | Pfizer-BioNTech | No |
| 4 | 2022-04-07 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Slight inflammation at site. Firmness in arm at site about 40cm diameter .
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): None
Systemic reaction (other): Slight discomfort at injection site
Release 10 — day 14, dose 3
Symptoms: None
Release 10 — 3 months, dose 3
Symptoms: Runny nose. Chills fatigue
Release 12 — 3 months, dose 4
Symptoms: Covid positive antigen june 18. Took Paxlovid. With significant improvement. Had rebound and receive script for second round of Paxlovid but did not have to take. I weathered the storm and now I just have slight congestion with no fever.
Healthcare visit (other): Got Script for anti viral
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Viral infection | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | No adverse event | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Injection site discomfort | · | · | ✓ |
| SRO | Injection site induration | ✓ | ✓ | ✓ |
| SRO | Injection site inflammation | ✓ | ✓ | ✓ |
| SRO | No adverse event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release